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Memory deficits are widely reported in patients with schizophrenia, but uncertainties
remain about the extent and the longitudinal course of these deficits. Twenty-eight
patients with a DSM-IV diagnosis of schizophrenia were tested on multiple aspects of
memory at baseline, 9- and 18-month follow-up. Measures included: digit span, the
Rivermead Behavioural Memory test (RBMT) battery, the Graded Naming Test (GNT)
and several computerized memory tests from the Cambridge Automated Neuropsycho-
logical Testing Battery (CANTAB). A group of healthy controls (N=17) was tested on
the CANTAB battery at baseline and 9-month follow up. The patients performed
significantly poorer than controls on all CANTAB measures; however, there was no
difference in change between groups over a 9-month period. Within-group patient
comparisons revealed that symptoms reduced significantly over the study period, but
had no association with memory. Significant improvements were observed for patients
on two verbal memory tasks: the GNT and digit span, but not on any other measure.
Interestingly, these were the only two tests on which patients were within normal limits
at baseline. This study shows that patients with schizophrenia have deficits in multiple
aspects of memory which remain stable over long periods of time. In addition, patients
showed a tendency to improve on memory tasks which contained a verbal component.
Introduction
Little doubt remains that patients with schizophrenia have substantial memory deficits
(e.g., Aleman Hijman, de Haan & Kahn, 1999), and these are often disproportionate to the
general level of intellectual impairment and other aspects of cognitive function (Saykin
et al., 1991; McKenna et al., 1990). It appears that multiple aspects of memory are affected
because deficits have been reported in short term memory (e.g., Aleman et al., 1999; Conklin,
Curtis, Katsanis & Iacono 2000), working memory (e.g., Minor & Park, 1999; Pukrop
et al., 2003), semantic memory (e.g., Granholm, Chock & Morris 1998; Laws, Al-Uzri &
Mortimer 2000), episodic memory (e.g., Cannon et al., 2000; Mellers, Toone & Lishman,
2000), recognition memory (e.g., Crespo-Facorro et al., 2001; Tracey et al., 2001) and
recall (e.g., Paulsen et al., 1995; Putnam & Harvey, 1999).
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Nevertheless, an important and unresolved question relates to the longitudinal course
of memory deficits. Are they stable? Do they fluctuate with symptom exacerbation and
remediation or medication effects? Is there a progressive deterioration? An answer to
these questions can shed light on ‘trait’ or ‘state’ theories of the origins of the memory
deficits. Trait theories suggest that deficits are the result of structural abnormalities that
are stable and largely unchanging. State theories suggest that memory deficits are unstable
and result from neurochemical or neurophysiological disturbances which change over
time in relation to medication effects and / or fluctuations in symptom profile. It is also
plausible that memory dysfunction in schizophrenia involves both theories, with some
functions being impaired and stable, whilst others fluctuate (Nopoulos, Flashman, Flaum,
Arndt & Andreasen 1994). In addition, the possibility remains that some aspects of
memory deteriorate over time. This suggestion is consistent with the classic Kraepelinian
notion of ‘dementia praecox’.
Previous investigations of the stability of memory function in patients with schizo-
phrenia have produced mixed results, with about less than half reporting change in either
direction (See Table 1). Of those studies that have reported change, some have reported
improvements in verbal memory (Addington, Addington & Maticka-Tyndale 1991; Albus
et al., 2002; Bilder et al., 1991; Gold et al., 1999; Sweeney, Haas, Keilp & Long 1991),
visual memory (Addington et al., 1991; Albus et al., 2002); and short term memory (Rund,
Landro & Orbeck, 1997). Conversely, others have reported deteriorations in visual mem-
ory and short term memory (Albus et al., 2002; Bilder et al., 1991). Such heterogeneity is
underlined by the fact that all of those studies reporting some change(s) also reported no
change on other memory tests. Moreover, the studies used a variety of methodologies that
may also account for discrepant findings (e.g., differing lengths of illness, medication,
symptom profiles and so on). Nevertheless, most of the previous studies have only
focussed on two or three distinct aspects of memory and therefore the temporal stability of
several important aspects of memory has not been previously investigated. These include
pattern recognition, spatial recognition, spatial working memory, spatial short term
memory and episodic memory.
Additionally, where different studies have assessed the same aspects of memory, the
tests used have usually been different which limits the general conclusions that can be
drawn. For example, of the six studies that have explored the temporal stability of verbal
short term memory, three different types of tests have been used: two versions of the digit
span test (Oltmanns & Neal, 1975; Wechsler, 1981), and the distractor technique
(Peterson & Peterson, 1959). Another problem is that most studies have assessed patients
only twice—at baseline and at follow-up. With this approach it is possible that short term
fluctuations in performance at either time point—for example, reflecting motivational
changes, the commencement or discontinuation of medications, or even regression to the
mean might confound the results. To get a clearer and more definitive picture of the long
term stability of memory function in schizophrenia, multiple follow-up assessments are
needed.
Finally, additional important issues arise for longitudinal studies of cognitive perfor-
mance in schizophrenics or any other group. Longitudinal studies are, by their very nature,
suspect to a variety of problems that do not occur with snapshot studies and are different
to those in cohort studies. Problems include patient drop-out, potentially reduced samples
for follow-up examinations both of patients and of controls, length of follow-up that is
practical, changes in medication, symptom status and so on. These problems are balanced,
however, by the fact that some questions concerning the natural history of disorders can-
not be definitively addressed using snapshot or cohort studies. This is especially true of
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6 P. Tyson et al.
cohort studies when one considers the degree of cognitive and symptomatic heterogeneity
in samples of schizophrenics.
Some problems associated with past studies may, however, be readily addressed.
The first concerns the reliability of memory tests themselves. Obviously if tests have
low reliability this can lead to apparent change in cognitive function. In this case, it is
notable that the reliabilities of the memory scores are often poorer than for other cogni-
tive skills especially for delayed retention measures (Goldstein & Watson, 1989;
McCaffrey & Westervelt, 1995; Mitrushina & Satz, 1991). Indeed, the longitudinal sta-
bility of memory in patients with schizophrenia has been investigated using various
subscales of the Wechsler memory test and other standardised memory measures
(see Table 1); however, some have quite low reliability (see Dikmen, Heaton, Grant &
Temkin, 1999). For example, the paired associates test has a test-retest reliability of
.58; visual reproduction .62; logical memory is better at .70). A second major issue
concerns separating practice effects from genuine change. Obviously when retested,
some change may reflect practice. To address this, it is necessary to include a control
sample to determine the degree of practice effect that may exist on tests. Examining the
studies of memory in schizophrenia in Table 1, a minority (6/13) included controls
(Albus et al., 2002; Censits, Ragland, Gur & Gur, 1997; Heaton et al., 2001; Rund,
1989; Rund and Landro, 1995; Rund et al., 1997). Given the normal impact of aging on
memory, it is also necessary to match controls with the patients on such relevant
variables.
The aim of the following study is to provide a comprehensive investigation of the
stability of memory function in schizophrenia. The study details the longitudinal
course of aspects of memory that have not been previously investigated and attempts to
address some of the flaws in previous studies by choosing memory tests with higher
reliability and by examining the influence of practice by including a matched control
comparison group tested at the first two time points. The patients were selected for
testing to fit a variety of criteria, including that they: met all of the usual exclusion
criteria (history of head injury or other neurological problem, evidence of drug or alco-
hol abuse); had normal estimated premorbid intellectual functioning; no sign of
dementia; were similar in age to patients in previous studies; and displayed a wide
range of length of illness. Given the variability in previous studies, we attempted to
select a group that was relatively comparable with most previous studies. A secondary
aim of this study is to investigate associations between memory function and I.Q.,
symptoms and medication.
Materials and Methods
Patients
Twenty-eight patients (18 males; 10 females) with a DSM-IV diagnosis of schizophrenia
were recruited from inpatient and outpatient units in East Yorkshire, UK. DSM-IV diag-
nosis was made using both a clinical interview and a review of the patient’s history. This
was completed by AMM, Professor of Psychiatry at the University of Hull. Patient selec-
tion was also based on the following criteria: age between 18 and 60; no history of neuro-
logical disease or head trauma; no history of drug or alcohol abuse. All were screened for
global cognitive impairment using the Mini Mental State Examination (MMSE: Folstein,
Folstein & McHugh 1975) and their mean of 27 (SD= 2; range 22-30) indicates that the
majority of the group are functioning within the normal cognitive range (one patient
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scored below the 24 cut-off). The Brief Psychiatric Scale (BPRS) was used to assess
symptom type and severity (Hedlund & Vieweg, 1980).
The average age of the sample was 34 years (SD = 10; range 18–54) and so compara-
ble with similar longitudinal studies (mean age in Table 1 was 33.5). At the time of their
inclusion in the study, the patients had an average length of illness of 8 years; however, we
selected a wide range of illness length: from 3 weeks to 38 years (SD = 9 years). The mean
score on the BPRS was 15 although there was considerable variance in symptom presence,
with patients scoring between 2 and 28. When the BPRS score was broken down accord-
ing to the four symptom dimensions identified by Overall (1976), the ratings were: think-
ing disturbance (mean = 5.9, SD 3.4, range 0–12); withdrawal/retardation (mean = 2.7, SD
3.5, range 0–13); hostility/suspiciousness (mean = 2.4. SD 2.0, range 0–9), and anxiety/
depression (mean = 7.0, SD 3.2, range 1–14). Patients were on the following antipsychotic
medications for the duration of the study (patient numbers and mean daily dose at baseline
in brackets); Chlorpromazine (N−1; 200 mg), Olanzapine (N = 4; 10mg), Clozapine (N = 8;
209mg), Quetiapine (N = 5; 330 mg) Risperidone (N = 6; 4mg), Amisulpride (N = 4;
550mg). Only one patient was on typical neuroleptics and anticholinergics1. Antipsychotic
dosages were converted to the Percentage of Maximum Dose (PMD) according to the
British National Formulary (BNF, 2004) in order to investigate associations between dos-
age and neuropsychological test performance. This method of comparing antipsychotic
potency is considered more reliable than using chlorpromazine equivalents (Yortson &
Pinney, 2000). There was minimal change in medication dosage over the study period.
Controls
Seventeen non-psychiatric controls who were sampled from non-academic staff at the
University of Hull and who were demographically similar to the patient group were
included in the study. The controls were matched with the patients for age (39.4 vs. 33.85:
t43 = −1.69, p > .05) and estimated premorbid IQ (106.17 vs. 101.17: t43 = −1.29, p > .05)
as measured by the National Adult Reading test (NART: Nelson, 1982).
Tests and Procedure
Patients were assessed on all memory measures at baseline, 9-month and 18-month
follow-up. These time intervals were set in order to get a long-term picture of memory
function in schizophrenia. Indeed, many previous follow-up studies of cognition in
schizophrenia have been criticised for their short-term focus (Keefe, Silva, Perkins &
Lieberman, 1999). Memory tests were chosen to reflect a full range of memory abilities
and to include tests that have good reliability (see below).
Digit span test (DS: Wechsler, 1981)
This test is considered to reflect short-term auditory memory and requires a subject to
repeat an increasing sequence of numbers in the same order as they have been read to
them. The reliability for the DS tests is high (.88: Wechsler 1987).
1 The performance of this patient was not different from those not taking anticholinergics.
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Rivermead Behavioural Memory Test (RBMT: Wilson, Cockburn & Baddeley, 1985)
This test provides an ecologically valid assessment of everyday memory function. This
battery comprises the following subtests:
• Remembering a name (given the photograph of a face)
• Remembering a belonging (a belonging of the subject is concealed and the subject
has to remember to ask for it back at the end of the session)
• Remembering a message after a delay (the subject is told to say some key words
when an alarm rings after 20 minutes)
• An object recognition task (10 pictures of objects are shown, and the subject then
has to recognize these out of a set of 20 pictures shown after a delay)
• A face recognition task (similar to object recognition, but using five faces to be rec-
ognized amongst five distracters)
• A task requiring the subject to remember and follow a route around the room both
immediately and after a delay
• Delivering a message—whilst retracing the route around the room the subject has to
remember to place a message envelope in a specific place
• Recall of a short story both immediately and after a delay
• Orientation and date questions
The RBMT test-retest reliability for the profile score (combining all subtests) used here is .85
Graded Naming Test (GNT: McKenna & Warrington, 1983)
This test of naming to picture taps aspects of lexical/semantic memory. There is no
reliability data for the GNT; however, as a test of lexical-semantic ability, rather than
episodic memory it should have high reliability. For example, the highly comparable
Boston Naming Test has a test-retest reliability of .92 (Dikmen et al., 1999).
Cambridge Automated Neuropsychological Testing Battery (CANTAB)
The remaining tests were taken from the Cambridge Automated Neuropsychological Testing
Battery (CANTAB: Morris, Evenden, Sahakian & Robbins 1987). This is a computerized
battery of tests that are presented on a touch screen computer:
Pattern and Spatial Recognition
These tests follow the traditional structure of recognition memory tests where subjects
have to pick out items they have previously seen. The pattern recognition test utilizes
colored, nonverbalizable patterns that are displayed individually during the presentation
stage of the task, and with a distracter during the recognition stage. The same procedure is
utilized for the spatial recognition task except that the stimuli are white squares appearing
at random locations on the computer screen. Recognition scores for both tests are
converted to a percentage of the total correct responses made.
Spatial Span
This is a computerised analogue of the Corsi block-tapping test (Milner, 1971) and
requires the subject to observe and remember the sequence and location of a series of
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boxes changing color. Scoring on this test is in terms of the maximum sequence of squares
changing color that the subject could successfully follow (between 2 and 9).
Spatial Working Memory
This test requires the subject to search through an increasing number of boxes on the
computer screen in order to locate tokens. Once a token has been found in a particular box,
another will not appear in the same box and therefore the subject has to keep track of the
locations where they have previously found tokens and remember not to re-search that
box. The main type of error that is recorded on this test is a between–search error when
the subject returns to a box where a token was previously found. In addition, a score
representing the strategy used to complete the task is also recorded. An optimum strategy
would be for the subjects to follow a pre-planned search sequence, starting with one box
and returning to that box at the beginning of a new search after a token has been found.
A high strategy score would be obtained if the subject used the same starting location for
the search within each of the six and eight box problem. A low score represents random
starting positions for each search. The range of strategy score is between 1 (optimum) and
37 (very poor).
As noted above, memory tests often have low reliability. In a recent review of the
Test Retest Reliability (TRR) of memory tests, Paolo (1998) introduced a categorical
system of TRR coefficients, declaring >0.8 to be ‘good’, 0.6–0.8 to be ‘fair’ and scores of
<0.6 to be ‘poor’. As noted by Paolo, the application of this system to the TRR of a num-
ber of well-known memory tests shows that the majority of tests fall within the fair cate-
gory, though some are clearly poor. Two studies (CeNeS, 2000; Lowe and Rabbitt, 1998)
have examined the TRR reliability for the CANTAB battery. According to the Paolo
criteria, the Pattern Recognition test (.72, .84) has good reliability; the Spatial Working
Memory test (.70, 68) and the Spatial Span task (.60, .64) are fair; however, the Spatial
Recognition test (.48, .57), has poor reliability (although the reasons for these lower
reliabilities are unclear).
Results
Between-groups (Baseline to 9 Months)
There was no evidence of either floor or ceiling effects in the data for patients or controls.
Separate two-way ANOVAs with time (baseline and 9 months) and group (patients and
controls) as factors were used to analyze data from the CANTAB tests. In each case, the
patients performed significantly worse than controls, but the main effect for time and the
interaction for group-by-time were not significant. Hence, although showing worse memory,
there was no evidence of greater change in the schizophrenic patients than controls over
9 months.
Memory scores for patients correlated widely and significantly with NART IQ at
most time points (baseline correlations are in Table 2); however, covarying for baseline IQ
made no difference to the results.
Within Patient Comparisons Over 18 Months
Further data was available for the patients at an 18 month follow-up and this was analyzed
using a within-patient ANOVA to analyze patient change (see Table 3). Except for a trend
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for spatial span to improve (reflecting a significant 9 to 18 month improvement: t27 = 2.3,
p = .03), there were no significant effects of time on the memory performance in the
patients and so, accords well with the control-based comparisons.
Additionally, patient data for the three times was available for the Graded Naming
Test, Rivermead Behavioural Memory Test battery and forward digit span. On the GNT
and digit span, the patients showed significant improvement and were within the low-
average normal range at baseline (see Table 4); in both cases this reflected an improve-
ment between baseline and 18 months (t25 = 2.7, p = .01 and t26 = 3.7, p = .005). Critically,
the GNT scores did not differ from those predicted by their NART IQ scores (t25 = 0.11,
p = 0.88). By contrast, compared to test norms, their RBMT scores indicated poor memory
and this did not change significantly across time. Finally, we combined the visual and
verbal subtests of the RBMT into a visual and a verbal memory score—neither revealed
changes across time (both F < 1).
Symptoms and Medication
Analysis of BPRS scores over 18 months revealed a significant decrease in symptoms
(F1, 27 = 37.5, p = .000: baseline 15.29 ± 7.12; 9 months 9.75 ± 7.38; and 18 months
Table 2
Correlations between baseline memory tests and 
NART IQ in schizophrenic patients
Baseline memory scores NART IQ
Spatial span .36
Pattern recognition .38
Spatial recognition .51
Spatial working memory strategy −.29
Spatial working memory error −.67
GNT .42
RBMT .46
Digit span .36
* Except for digit span and SPWMS, all p < .05.
Table 3
Longitudinal performance of schizophrenics on the CANTAB memory tests
Memory scores
Baseline
Mean[SD]
9 months 
Mean[SD]
18 months 
Mean [SD] Time difference
Spatial span 4.89 [1.70] 4.86 [1.76] 5.39 [1.31] F2, 54 = 2.77, p = .07
Pattern recognition 77.63 [13.78] 77.77 [14.38] 80.55 [15.10] F2, 52 = 0.58, p = .56
Spatial recognition 71.29 [13.56] 67.96 [14.29] 70.18 [13.19] F2, 52 = 0.51, p = .60
Spatial working
memory strategy
36.77 [5.25] 34.46 [5.51] 35.15 [5.02] F2, 50 = 2.19, p = .12
Spatial working 
memory error
45.08 [25.74] 40.15 [21.92] 38.96 [22.26] F2, 50 = 1.22, p = .30
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8.61 ± 5.48). Indeed, only 3/28 (<10%) patients failed to show improvement. The reduc-
tion reflected a significant decrease in symptoms from baseline to 9 months (t27 = 5.02,
p = .000); the change between 9 and 18 months was nonsignificant (t27 = 1.2, p = .23).
Despite the change in symptoms, there were no significant correlations between the
BPRS change scores (baseline to 9 months; 9 months to 18 months) and changes in mem-
ory or memory at baseline (the vast majority of correlations were between zero and .1).
Finally, turning to potential medication effects, there were no significant correlations
between the percentage of maximum dose and any test at any time point.
Discussion
The aim of this study was to examine various aspects of memory in patients with schizo-
phrenia and to determine which areas of memory are impaired, whether they are stable
across time and how (if at all) they might relate to factors such as IQ, symptoms and
medication. The current study used a large battery of memory tests to examine a wide
range of memory abilities, including: visual and verbal, short-term and long-term,
episodic and semantic, recall and recognition. Patients with schizophrenia consistently
performed worse than controls (and/or below normative levels) on the tests. Although IQ
correlated with memory performance in patients (as expected), covarying for IQ made no
difference to the outcome of analyses. Hence, the memory problems are not attributable to
any general intellectual deficit and would appear to be stable across time (at least for
18 months) for most aspects of memory. Nevertheless, it should be noted that the measure
of IQ was an estimate of premorbid functioning and the patients were relatively normal on
this measure. Hence, the results could be different for premorbidly less capable individuals
or if a measure of current IQ (such as the WAIS) were used.
The patients did show a relatively more intact performance on some more verbally-
based tasks and this was accompanied by significant improvement across time for 2 of 3
verbal tasks (digit span and picture naming). These positive changes may be due to the
effects of the atypical antipsychotics used in the current study, as several of these have
been shown to enhance verbal functioning in patients with schizophrenia (Green et al.,
1997; Keefe et al., 1999). All aspects of memory performance were independent of
symptom ratings and level of medication.
Given our largely null result, it is, of course, feasible that our study lacked power
because of the sample size2. Nevertheless, our sample size was comparable with the
average in past studies (see Table 1); and if anything, past positive findings emerged in
studies using smaller or comparable sample sizes (and most null results have emerged in
the larger studies). This suggests that change (across comparable or shorter periods)
should be detected with samples of this size. Along with the fact that we used a large
memory battery and our inclusion of memory tests with higher reliabilities (than those
typically used in previous studies) also leads us to believe that our null findings should not
be dismissed as a product of a small sample and any consequent power problems. Despite
this, the test-retest reliability coefficients were somewhat lower for two tests: spatial span
and spatial recognition (though comparable to some previously used memory measures).
If anything, the finding of impaired memory in patients on tests with both high (digit span,
RBMT, spatial recognition, pattern recognition) and low reliability (spatial span and
2 A post hoc power analysis showed that for the smallest effect size obtained (.5), the power to
detect group differences was .7.
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spatial recognition) indicates that the failure to find time related changes is not attributable
to reliability issues.
Previous research in this area has yielded conflicting results which is perhaps unsur-
prising given the differences in: medications prescribed (typicals vs. atypicals), methodologies
employed, tests used, number of patients recruited, length of follow-up period and the
poor reliability of many memory tests. Nevertheless, some consistent findings have
emerged. Only 2 of 13 studies, that have explored the temporal stability of memory
function in schizophrenia, have found that aspects of memory worsen over time. Although
Bilder et al. (1991) reported that digit span and visual span declined over 12 months, these
findings were not replicated in several other studies that also measured the same abilities
(Addington et al., 1991; Heaton et al., 2001; Hoff et al., 1992; Rosmark et al., 1999; Rund &
Landro, 1995; Rund et al., 1997; Sweeney et al., 1991). In addition, the finding by Albus
et al. (2002) that visual reproduction declined over a 24-month period is also not consis-
tent with previous research (Gold et al. 1999; Heaton et al. 2001; Hoff et al., 1992; Nopo-
polous, 1994; Sweeney et al., 1991). Hence, as with the majority of previous studies, the
current study accords with the notion that memory function is substantially impaired, but
does not progressively deteriorate in schizophrenia; and may improve in some cases for
some aspects of memory (principally verbal in this study).
In the current study, we found no association between memory and medication
dosage at any time point. Although a link between memory changes and medication has
been reported (Albus et al., 2002; Rund et al., 1997; Sweeney et al., 1991), others have
found no link (Censits et al., 1997; Nopoulus et al., 1994; Saykin et al., 1994) and the
recent meta-analysis by Aleman et al. (1999) indicates that medication dosage is not a
moderator of memory function in schizophrenia. Another unresolved and related issue
concerns any association between memory changes and psychotic symptoms. Although
several studies, including the current one, have found no association (Addington et al.,
1991; Albus et al., 2002; Gold et al., 1999; Heaton et al., 2001; Nopoulus et al., 1994),
others have reported an association (Censits et al., 1997; Hoff et al., 1992; Rund et al.,
1989; Sweeney et al., 1991). As noted, schizophrenic patients are quite heterogenous in
their cognitive performance and symptom profiles and so our results may reflect certain
characteristics of this cohort, e.g., their tendency to show symptom improvement across
time. Unfortunately, we could not compare a set of patients who did and did not improve
because only 3/28 failed to improve during the study. Nevertheless, the current results do
accord with the meta-analysis of Aleman et al. (1999) who showed that neither severity of
symptoms nor illness duration moderate memory performance. Significant improvements
were observed in short-term memory and semantic memory. Clearly, these tests are different
from the rest of the battery because both are verbally based, and several previous studies
have reported improvements in verbal memory (Addington et al., 1991; Albus et al., 2002;
Bilder et al., 1991; Gold et al., 1999; Rund et al., 1997; Sweeney et al., 1991). Digit span
does usually provide a lower effect size than other aspects of memory generally (.71 vs.
1.21: Aleman et al., 1999). With regard to the GNT, this is intriguing because severe
deficits have been documented in patients with schizophrenia (e.g., Garbrovska, Laws,
Sinclair, McKenna, 2000; Laws, Al-Uzri and Mortimer 2000). The patients in the current
study were, however, younger than those tested by Laws et al. and Gabrovska et al.
(33 vs. 46 and 42 years) and had been ill for much less time (8 vs. 23 and 20 years). It is
therefore feasible that protracted illness leads to greater deficits in semantic and lexical
memory. While length of illness may not directly relate to degree of memory impairment,
it may be that different types of memory impairment occur at different points during the
course of the illness. For example, semantic memory impairment may occur after episodic
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impairment. Indeed, Al-Uzri, Laws and Mortimer (in press) have also recently shown that
picture naming is intact in younger schizophrenic patients (mean age = 34, illness duration
11 years).
To return to our empirical questions, it seems that many memory functions are
impaired quite early in the course of illness and remain quite stable (at least over
18 months). Nevertheless, one novel finding from this study concerns semantic lexical
memory and how that remains intact even in patients with quite severe episodic memory
deficits (both for verbal and nonverbal material). Similarly, digit span remained well
within the normal range and even showed a tendency to improve (as did name GNT per-
formance). The intriguing aspect of these findings is that we know from other studies that
performance on these tasks is impaired (and very severely) in older patients with more
chronic length of illness. This suggests that in schizophrenic patients, lexical semantics
may hold up better and for longer than their episodic memory which shows substantive
but stable impairments.
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